Penn spinout and I-Corps participant NeuroFlow has raised a $25 million growth round led by Wayne-based SemCap Health.
The funding will help Neuroflow, a Philadelphia-based mental health startup, make greater investments in research and development, expand its technology platform and increase headcount.
Founded in 2017 by COO Adam Pardes and CEO Christopher Molaro, Neuroflow’s platform can track patients’ moods, pain levels and sleep through self-assessment. Healthcare providers can then use it to identify behavioral health conditions and integrate it into a care plan. It helps patients connect with the right level of care with the intention of ultimately lowering costs associated with mental health treatments.
Neuroflow has been rapidly growing over the past year, moving into a 16,000-square-foot office at 1601 Market St. last month and more than doubling its headcount over the past year to about 100.
Neuroflow is also set to more than double its revenue year over year, including more than seven figures worth of deals in September alone. Over the past year, Neuroflow’s platform jumped from supporting 2 million people to 15 million, either directly through payors or indirectly through health care systems.
To learn more about Neuroflow and its recent funding, go here.
